Related Experiment Video
Updated: Aug 8, 2026

12:45
Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
Atrial natriuretic factor secretion in dogs with experimental high-output heart failure
The American Journal of Physiology
|April 1, 1987
Summary
In dogs with heart failure, atrial natriuretic factor (ANF) levels rise over time, helping to restore sodium balance. This increase in ANF inhibits the renin-aldosterone system, promoting fluid excretion.
Area of Science:
- Cardiology
- Endocrinology
- Renal Physiology
Background:
- Chronic high-output heart failure models are crucial for understanding cardiac decompensation.
- Arteriovenous (AV) fistula in dogs creates a model of sustained volume overload and cardiac stress.
- Atrial natriuretic factor (ANF) is implicated in regulating fluid and electrolyte balance.
Purpose of the Study:
- To investigate the temporal changes in plasma immunoreactive atrial natriuretic factor (iANF) in a canine model of chronic heart failure.
- To determine the relationship between iANF levels, sodium balance, and the renin-aldosterone system during the progression of heart failure.
- To elucidate the role of ANF as a compensatory mechanism in chronic cardiac volume overload.
Main Methods:
- Utilized six conscious dogs with surgically created arteriovenous (AV) fistulas to induce chronic high-output heart failure.
- Monitored plasma iANF concentrations, plasma renin activity, plasma aldosterone concentration, and right atrial pressure over a 14-day period.
- Assessed daily sodium excretion and balance to evaluate renal handling of sodium.
Main Results:
- Following AV fistula creation, dogs initially exhibited sodium retention, elevated plasma renin activity, aldosterone, and right atrial pressure, with only modest iANF increase.
- Between days 6 and 14, dogs achieved sodium balance, accompanied by a significant rise in iANF.
- This natriuretic phase correlated with normalized renin and aldosterone levels and persistently elevated right atrial pressure.
Conclusions:
- Chronic increases in atrial pressure serve as a sustained stimulus for ANF release in dogs with AV fistula-induced heart failure.
- Elevated ANF levels contribute to chronic endocrine adjustments, reestablishing sodium balance by inhibiting the renin-aldosterone axis.
- The ANF endocrine system acts as a compensatory mechanism promoting sodium and water excretion in heart failure via renin-aldosterone suppression and potential direct renal effects.
Related Concept Videos
Heart Failure Drugs: Inotropic Agents
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...

